Posted: December 15, 2008

NanoInk's New NanoBioDiscovery Division to Focus on Biomarker and Drug Discovery

(Nanowerk News) NanoInk, Inc., one of the world’s leading nanotechnology enterprises, announced today the launch of its NanoBioDiscovery Division. The new division will utilize Dip Pen Nanolithography® nanofabrication techniques, in combination with proprietary detection systems, to produce uniquely sensitive assays for protein discovery and identification. Femtofluidics handling of samples and reagents with these systems will help provide key benefits for users, including enhanced reaction kinetics and assay cost savings.
Bruce Dudzik, NanoInk’s Senior Director for Business Development, is leading the new unit. He summarized the division’s customer benefits by saying, “If you’re working in drug discovery, our company can help you find new drug targets that were previously out of reach and help identify compound safety issues earlier in the research process, so you save both time and money.”
In addition, Mr. Dudzik emphasized that the new division will be accessible to customers of all sizes. “If acquisition costs and training are a problem,” he said, “our contract research group can give you great results and invaluable experience with our system.”
James M. Hussey, CEO of NanoInk, added these thoughts, “NanoInk is committed to developing applications for Nanofabrication and partnering to find solutions for the challenges associated with Life Science Research.”
About NanoInk
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using the Dip Pen Nanolithography® patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign. For more information on products and services offered by NanoInk, Inc., see
Source: NanoInk (press release)
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: